Related Experiment Video
Updated: Jun 6, 2026
10:04
Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells
Published on: August 1, 2025
Dendritic cells and immunity against cancer
1Baylor Institute for Immunology Research, Baylor University Medical Center, Dallas, TX, USA. karolinp@baylorhealth.edu
Journal of Internal Medicine
|December 17, 2010
Summary
Novel cancer vaccines can enhance T cell therapies by overcoming immune suppression. Strategies targeting dendritic cells (DCs) and regulatory T cells (Tregs) aim to improve adaptive immunity against tumors.
Area of Science:
- Immunology
- Cancer Therapy
- Vaccinology
Background:
- Adoptive T cell transfer shows immune system's cancer-fighting potential but faces challenges in long-term T cell maintenance.
- Current cancer vaccines have limited efficacy in metastatic disease due to tumor-induced immune suppression by myeloid-derived suppressor cells, type 2 T cells, and regulatory T cells (Tregs).
Purpose of the Study:
- To design novel cancer vaccines that boost adaptive immunity, overcome Tregs, and break down the immunosuppressive tumor microenvironment for improved clinical efficacy.
- To leverage the understanding of dendritic cell (DC) subsets and their functional plasticity to generate unique adaptive immune responses against cancer.
Main Methods:
- Exploiting knowledge of the dendritic cell (DC) system, including distinct DC subsets and their differential responses to activation signals.
- Developing strategies to overcome regulatory T cells (Tregs) and the immunosuppressive tumor microenvironment.
Main Results:
- The study proposes novel cancer vaccine strategies based on dendritic cell (DC) biology and functional plasticity.
- These strategies aim to enhance effector and memory T cell generation and function.
Conclusions:
- Novel cancer vaccines hold promise for monotherapy in resected disease and combination therapy with immunomodulatory drugs in metastatic disease.
- Harnessing DC system knowledge and functional plasticity is key to overcoming immune suppression and improving cancer vaccine efficacy.
Related Concept Videos
01:40Cell-mediated Immune Responses
Overview
01:27Cytotoxic T Cells-mediated Immune Response
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
01:22Antigen Presenting Cells
The immune system is a complex network of cells and molecules that protects the body from foreign invaders. T cells, a type of white blood cell, play a crucial role in this process. They recognize and attack foreign substances, such as pathogens, that enter the body.
T cells require the help of antigen-presenting cells (APCs), which process foreign antigens into smaller fragments that can be recognized by T cells. These APCs are highly specialized cells that efficiently internalize antigens...
T cells require the help of antigen-presenting cells (APCs), which process foreign antigens into smaller fragments that can be recognized by T cells. These APCs are highly specialized cells that efficiently internalize antigens...
01:26Antigens Involved in Adaptive Immunity
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
01:29Immune Response Against Viral Pathogens
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
01:28Cells of the Innate Immune Response
The innate immune response is an immediate and non-specific response against pathogens, acting swiftly to prevent the spread of infections. The primary cells involved in this response are phagocytes and natural killer (NK) cells.
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...